Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
May 19 2023 - 4:28PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2023
Commission File Number: 001-39034
BELLUS HEALTH INC.
(Translation of registrant’s name
into English)
275 Armand-Frappier Blvd.
Laval, Québec
H7V 4A7
Canada
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ¨ Form 40-F x
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7):
DOCUMENTS FURNISHED AS PART OF THIS FORM 6-K
A Notice of Special Meeting of Shareholders and Management Information
Circular
Form of Proxy for Registered Shareholders
A Letter of Transmittal
Exhibits
99.1 – A Notice of Special Meeting of Shareholders and Management Information Circular
99.2 – Form of Proxy for Registered Shareholders
99.3 – A Letter of Transmittal
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
BELLUS Health Inc. |
|
(Registrant) |
|
|
Date: May 19, 2023 |
By: |
/s/
Ramzi Benamar |
|
|
Name: |
Ramzi Benamar |
|
|
Title: |
Chief Financial Officer |
BELLUS Health (NASDAQ:BLU)
Historical Stock Chart
From Dec 2024 to Jan 2025
BELLUS Health (NASDAQ:BLU)
Historical Stock Chart
From Jan 2024 to Jan 2025